Pfizer Zeldox Approval Awaits QTc Comparison To Risperdal, Zyprexa
Executive Summary
Pfizer will compare the QTc interval prolongation of its antipsychotic Zeldox to Lilly's Zyprexa (olanzapine) and Janssen's Risperdal (risperidone) as a condition for approval.